Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
46.13
+0.99 (+2.20%)
Streaming Delayed Price
Updated: 3:35 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi - American Depositary Shares
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
41
42
Next >
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
↗
April 14, 2022
Via
Benzinga
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
April 13, 2022
Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent...
Via
FinancialNewsMedia
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
↗
April 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
↗
March 30, 2022
Via
Benzinga
Why Is IGM Biosciences (IGMS) Stock Up Today?
↗
March 29, 2022
Here are the various catalysts investors in IGM Biosciences and IGMS stock are watching today as shares more than double.
Via
InvestorPlace
Friday Stocks Update
↗
April 08, 2022
Royal Dutch Shell rose again on its earnings but is still at a p/e ratio of under 11x earnings.
Via
Talk Markets
Stocks That Hit 52-Week Highs On Thursday
↗
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
↗
April 07, 2022
Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
↗
April 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
↗
April 07, 2022
The
Via
Benzinga
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
↗
April 05, 2022
Via
Benzinga
Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May
↗
April 01, 2022
Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business.
Via
Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
↗
April 01, 2022
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.
Via
Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
↗
March 30, 2022
Via
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
↗
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
53 Biggest Movers From Yesterday
↗
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
↗
March 29, 2022
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
↗
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
↗
March 29, 2022
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
↗
March 29, 2022
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates
↗
March 29, 2022
U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning.
Via
Benzinga
IGM Biosciences Shares Surge After Oncology/Immunology Pact With Sanofi
↗
March 29, 2022
Sanofi SA (NASDAQ: SNY) and IGM Biosciences Inc (NASDAQ: IGMS) have signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
↗
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
↗
March 29, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration with Sanofi (NASDAQ: SNY). Guardforce AI Co.,...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings, Fed Speakers
↗
March 29, 2022
Pre-open movers
Via
Benzinga
Acurx Pharmaceuticals Stands As Front-Line CDI Treatment Contender After Pfizer Misses Primary Endpoint In CDI Drug Trial (NASDAQ: ACXP)
March 28, 2022
Via
AB Newswire
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
↗
March 28, 2022
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) have presented
Via
Benzinga
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
↗
March 24, 2022
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection.
Via
Benzinga
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
↗
March 21, 2022
After COVID-19 vaccine-induced strength, Moderna, Inc. (NASDAQ: MRNA) is on the lookout for the next big catalyst to boost its rangebound stock. The Moderna Analyst: BofA...
Via
Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
↗
March 21, 2022
U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases.
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
41
42
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
